Summary
At present, known risk factors account for only one-third of breast cancer cases diagnosed in the United States. They explain an even smaller fraction of the ten-fold variation in international breast cancer incidence rates. The low population-attributable risk of these identified risk factors, plus the existence of phenomena that cannot be easily explained by current etiologic hypotheses (such as the higher rate of breast cancer among black as compared to white women under age 40 within the United States), suggests that unidentified risk factors contribute substantially to breast cancer causation. This paper summarizes evidence to propose that two socially-conditioned factors determine a society's breast cancer incidence and its social gradients in risk: 1) the extent of exposure to exogenous carcinogens, and 2) breast tissue susceptibility to these exposures. It is further hypothesized that breast tissue susceptibility is inversely related to breast tissue differentiation, and that socially-mediated reproductive patterns (involving both early-terminated and full-term pregnancies) affect susceptibility both by altering (via hormonally-mediated mechanisms) the number and ratio of undifferentiated and differentiated cells, and by stimulating the growth of initiated and transformed cells. This view is presented in contrast to hypotheses that propose exposure to endogenous hormones as the major determinant of breast cancer risk.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- BBD:
-
Benign Breast Disease
- DDE:
-
Dichlorodiphenyl Dichloroethene
- ETP:
-
Early-Terminated Pregnancy
- FETP:
-
First Early-Terminated Pregnancy
- FFTP:
-
First Full-Term Pregnancy
- FTP:
-
Full-Term Pregnancy
- OC:
-
Oral Contraceptive
- PCB:
-
Polychlorinated Biphenyl
- RR:
-
Relative Risk
- SES:
-
Socioeconomic Status
- TDLU:
-
Terminal Ductal-Lobular Unit
References
U.S. Department of Health and Human Services: SEER program: cancer incidence and mortality in the United States, 1973–1981. NIH Pub. No. 85-1837. National Cancer Institute, Bethesda, MD, 1984
U.S. Department of Health and Human Services, Division of Cancer Prevention and Control: 1986 Annual Cancer Statistics Review. NIH Pub. No. 87-2789. National Cancer Institute, Bethesda, MD, 1987
American Cancer Society: Cancer Facts and Figures — 1987. American Cancer Society, New York, 1987
Donn AC, Muir CS: Breast cancer epidemiology and risk factors. In: Khogali M, Omar YT, Gjorgov A, Ismail AS (eds) Cancer Prevention in Developing Countries. Pergamon Press, Oxford, 1986, pp 155–166
Kelsey JL, Berkowitz GS: Breast cancer epidemiology. Cancer Res 48: 5615–5623, 1988
Kelsey JL, Hildreth NG: Breast and gynecological cancer epidemiology. CRC Press, Boca Raton FL, 1985
Vorherr H: Breast Cancer: Epidemiology, Endocrinology, Biochemistry and Pathobiology. Urban and Schwarzenberg, Baltimore MD, 1980
Henderson BE, Pike MC, Gray GE: The epidemiology of breast cancer. In: Hoogstraten B, McDivitt RW (eds) Breast Cancer. CRC Press, Boca Raton FL, 1981, pp 1–25
DeWaard F: Epidemiology of breast cancer: a review. Eur J Cancer Clin Oncol 119: 1671–1676, 1983
Boyle P, Leake R: Progress in understanding breast cancer: epidemiological and biological interactions. Breast Cancer Res Treat 11: 91–112, 1988
MacMahon B, Cole P, Lin TM: Age at first birth and breast cancer risk. Bull Wld Hlth Org 43: 209–221, 1970
Trichopoulos D, Hsieh CC, MacMahon B, Lin T, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S: Age at any birth and breast cancer risk. Int J Cancer 31: 701–704, 1983
Goodwin PJ, Boyd NF: Critical appraisal of the evidence that dietary fat is related to breast cancer risk in humans. JNCI 79: 473–485, 1987
Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Hennekens CH, Speizer FE: Dietary fat and the risk of breast cancer. N Engl J Med 316: 22–28, 1987
Rohan TE, McMichael AH, Baghurst PA: A population-based case-control study of diet and breast cancer in Australia. Am J Epidemiol 128: 478–489, 1988
Le MG, Moulton LH, Hill C, Kramer A: Consumption of dairy products and alcohol in a case-control study of breast cancer. JNCI 77: 633–636, 1986
La Vecchia C, Decari A, Francheschi S, Pampallona S, Togoni G: Alcohol consumption and the risk of breast cancer in women. JNCI 75: 61–65, 1985
Harvey EB, Schairer C, Brinton LA, Hoover RN, Fraumeni JF Jr: Alcohol consumption and breast cancer. JNCI 78: 657–661, 1987
Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Hennekens CH, Speizer FE: Moderate alcohol consumption and the risk of breast cancer. N Engl J Med 316: 1174–1180, 1987
Schatzkin A, Jones DY, Hoover RN, Philip PR, Brinton LA, Ziegler RG, Harvey EB, Carter CL, Licitra LM, Dufour MC, Larson DB: Alcohol consumption and breast cancer in the epidemiological follow-up study of the first National Health And Nutrition Examination Survey. N Engl J Med 316: 1169–1173, 1987
O'Connell DL, Hulka BS, Chambless LE, Wilkinson WE, Deubner DC: Cigarette smoking, alcohol consumption and breast cancer risk. JNCI 78: 229–234, 1987
Longnacker HP, Berlin JA, Orza JG, Chalmers TC: A meta-analysis of alcohol consumption in relation to risk of breast cancer. JAMA 260: 652–656, 1988
Webber W, Boyd N: A critique of the methodology of studies of benign breast disease and breast cancer risk. JNCI 77: 397–404, 1986
Wang DY, Fentiman IS: Epidemiology and endocrinology of benign breast disease. Breast Cancer Res Treat 6: 5–36, 1985
Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR: A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 128: 467–477, 1988
McPherson K, Vessey MP, Neil A, Doll R, Jones L, Roberts M: Early oral contraceptive use and breast cancer: results of another case-control study. Br J Cancer 56: 653–661, 1987
Hennekens CH, Speizer FE, Lipnick RJ, Rosner B, Bain C, Belanger C, Stampfer MJ, Willett W, Peto R: A casecontrol study of oral contraceptive use and breast cancer. JNCI 72: 39–42, 1984
Meirik B, Lund E, Adami HO, Bergstrom R, Christoffersen T, Bergsjo P: Contraceptive use and breast cancer in young women. Lancet ii: 650–654, 1986
Pike MC, Henderson BE, Casagrande JT, Rosario I, Gray GE: Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer 43: 72–76, 1981
Choi NW, Howe GR, Miller AB, Matthews V, Morgan RW, Munan L, Burch JD, Feather J, Jain M, Kelly A: An epidemiological study of breast cancer. Am J Epidemiol 107: 510–521, 1978
Hadjimichael OC, Boyle CA, Meis JW: Abortion before first livebirth and risk of breast cancer. Br J Cancer 53: 281–284, 1986
Ewertz M, Duffy SW: Risk of breast cancer in relation to reproductive factors in Denmark. Br J Cancer 58: 99–104, 1988
Helmrich SP, Shapiro S, Rosenberg L, Kaufman DW, Slone D, Bain C, Miettinen OS, Stolley PD, Rosenshein NB, Knapp RC, Leavitt T Jr, Schottenfeld D, Engle RL Jr, Levy M: Risk factors for breast cancer. Am J Epidemiol 117: 35–45, 1983
Kvale G, Heuch I, Eide GE: A prospective study of reproductive factors and breast cancer. I. Parity. Am J Epidemiol 126: 831–841, 1987
Kvale G, Heuch I: A prospective study of reproductive factors and breast cancer. II. Age at first and last birth. Am J Epidemiol 126: 842–850, 1987
McTiernan A, Thomas DB: Evidence for a protective effect of lactation on risk of breast cancer in young women: results from a case-control study. Am J Epidemiol 124: 353–358, 1986
Willett W, Stampfer MJ, Bain C, Lipnick R, Speizer FE, Rosner B, Cramer D, Hennekens CH: Cigarette smoking, relative weight and menopause. Am J Epidemiol 117: 651–658, 1983
Green A, Willett WC, Colditz GA, Stampfer MJ, Bain C, Rosner B, Hennekens C, Speizer FE: Use of permanent hair dyes and risk of breast cancer. JNCI 79: 253–257, 1987
Schairer C, Brinton LA, Hoover RN: Methylxanthines and breast cancer. Int J Cancer 46: 469–473, 1987
Korenman S: Reproductive endocrinology and breast cancer in women. In: Pike MC, Siiteri PK, Welsch C (eds) Banbury Report 8. Hormones and Breast Cancer. Cold Spring Harbor Laboratory, Cold Spring Harbor NY, 1981, pp 71–83
Musey VG, Collins DC, Musey PI, Martino-Saltzman D, Preedy JRK: Long-term effects of a first pregnancy on the secretion of prolactin. N Engl J Med 316: 229–234, 1987
Brinton LA, Hoover R, Fraumini JF Jr: Interaction of familial and hormonal risk factors for breast cancer. JNCI 69: 817–822, 1982
Henderson BE, Ross RK, Pike MC, Casagrande JT: Endogenous hormones as a major factor in human cancer. Cancer Res 42: 3232–3239, 1982
Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG: ‘Hormonal’ risk factors, ‘breast tissue age’, and the age-incidence of breast cancer. Nature 303: 767–770, 1983
Weisberger JH, Williams GM: Carcinogen testing: Current problems and new approaches. Science 214: 401–407, 1981
Wysowski DK, Comstock GW, Helsing KJ, Lau HL: Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemiol 124: 791–799, 1987
Myers F, Brown JB, Morrison AS, MacMahon B: Endogenous sex hormones, prolactin and breast cancer in premenopausal women. JNCI 77: 613–616, 1986
Siiteri PK, Simberg N, Murai J: Estrogens and breast cancer. Ann NY Acad Sci 464: 100–105, 1986
Cole P, Cramer D, Yen S, Paffenbarger R, MacMahon B, Brown J: Estrogen profiles of premenopausal women with breast cancer risk. Cancer Res 38: 745–748, 1978
MacMahon B, Cole P, Brown JB, Paffenbarger R, Trichopoulos D, Yen S: Urine estrogens, frequency of ovulation, and breast cancer risk: a case-control study in premenopausal women. JNCI 70: 247–250, 1982
Ernster VL, Wrensch MR, Petrakis NL, King EB, Miike R, Murai J, Godson WH III, Siiteri PK: Benign and malignant breast disease: initial study results of serum and breast fluid analyses of endogenous estrogens. JNCI 79: 949–960, 1987
Fishman J, Fukushima D, O'Connor J, Rosenfeld RS, Lynch HT, Lynch JF, Guirgis H, Maloney K: Plasma hormone profiles of young women at risk for familial breast cancer. Cancer Res 38: 4006–4011, 1978
Yu MC, Gerkins VR, Henderson BE, Brown JB, Pike MC: Elevated levels of prolactin in nulliparous women. Br J Cancer 43: 826–831, 1981
Hill P, Wynder EL, Helman P, Hickman R, Rona G, Kuno K: Plasma hormone levels in different ethnic populations of women. Cancer Res 36: 2297–2301, 1976
MacMahon B, Trichopoulos D, Brown J, Andersen AP, Cole P, DeWaard F, Kauraniemi T, Polychronopoulou A, Ravnihar B, Stormby N, Westland K: Age at menarche, urine estrogens and breast cancer risk. Int J Cancer 30: 427–431, 1982
Sukumar S, Carney WP, Barbacid M: Independent molecular pathways in initiation and loss of hormone responsiveness of breast carcinoma. Science 240: 524–526, 1988
Van Zwieten MJ: The Rat as an Animal Model in Breast Cancer Research. Martinus Nijhoff, Boston MA, 1984
Welsch CW, Nagasawa H: Prolactin and murine mammary tumorigenesis: a review. Cancer Res 37: 951–963, 1977
Berg JW: Clinical importance of risk factors for breast cancer. Cancer 53: 589–591, 1984
Seidman H, Stellman SD, Mushinski MH: A different perspective on breast cancer risk factors: some implications of nonattributable risk. CA-A 32: 301–313, 1982
Nomura AMY, Lee J, Kolonel LN, Hirohata T: Breast cancer incidence in two populations with different levels of risk for the disease. Am J Epidemiol 119: 496–502, 1984
Dorn HF: Illness from cancer in the United States. Public Health Reports 59(2): 33–35, (3): 65–67, (4): 97–115, 1944
Dorn HF, Cutler SJ: Morbidity from cancer in the United States: Part I — Variation in incidence by age, sex, race, marital status, and geographic region. U.S. Dept. of Health, Education, and Welfare Public Health Monograph No. 29. U.S. Government Printing Office, Washington DC, 1959
Cutler SJ, Young JL Jr: Third national cancer survey: incidence data. U.S. Government Printing Office, Washington DC, 1975
Gray GE, Henderson BE, Pike MC: Changing ratio of breast cancer incidence rates with age of black females compares with white females in the United States. JNCI 64: 461–463, 1980
White E, Daling JR, Norsted TL, Chu J: Rising incidence of breast cancer among young women in Washington state. JNCI 79: 239–243, 1987
Austin H, Cole P, Wynder E: Breast cancer in black american women. Int J Cancer 24: 541–544, 1979
Schatzkin A, Palmer JR, Rosenberg L, Helmrich SP, Miller DR, Kaufman DW, Lesko SM, Shapiro S: Risk factors for breast cancer in black women. JNCI 78: 213–217, 1987
Devesa SS, Diamond EL: Association of breast cancer and cervical cancer incidence with income and education among whites and blacks. JNCI 65: 515–528, 1980
U.S. Department of Health and Human Services: Report of the Secretary's task force on black and minority health, vol. 3: Cancer. U.S. Government Printing Office, Washington DC, 1986
Kumanyika S, Helitzer DL: Nutritional status and dietary patterns of racial minorities. In: U.S. Department of Health and Human Services, ed. Report of the Secretary's task force on black and minority health, vol. 2: Crosscutting issues in minority health. U.S. Government Printing Office, Washington DC, 1985, pp 118–190
Cronin FJ, Krebs-Smith SM, Wyse BW, Light L: Characterizing food usage by demographic variables. J Am Dietet Assoc 81: 661–673, 1982
Patterson BH, Block G: Food choices and cancer guidelines. Am J Public Health 78: 282–286, 1988
White E: Projected changes in breast cancer incidence due to a trend toward delayed childbearing. Am J Public Health 77: 495–497, 1987
U.S. Bureau of the Census: The social and economic status of the black population in the United States: An historical view, 1790–1978. Current Population Reports, Special Studies, Series P-23, No. 80. U.S. Government Printing Office, Washington DC, 1980
Hayes CD: Risking the future: adolescent sexuality, pregnancy and childbearing, Vol. I. National Academy Press, Washington DC, 1987
Krieger N: Rising incidence of breast cancer (letter). JNCI 80: 2, 1988
Ventura SJ, Taffel SM, Mosher WD: Estimates of pregnancies and pregnancy rates for the United States, 1976–85. Am J Public Health 78: 504–511, 1988
O'Hare WP: Black demographic trends in the 1980s. Milbank Memorial Fund Quarterly 65 (Suppl 1): 35–55, 1987
U.S. Bureau of the Census: Statistical Abstract of the United States: 1985 (105th edition). U.S. Government Printing Office, Washington DC, 1984, p 63
Cairns J: Mutation selection and the natural history of cancer. Nature 255: 197–200, 1975
Russo J, Tay LK, Russo IH: Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat 2: 5–73, 1982
Russo J, Calaf G, Roi L, Russo IH: Influence of age and gland topography on cell kinetics of normal human breast tissue. JNCI 78: 413–418, 1987
Potten CS, Watson RJ, Williams GT, Tickle S, Roberts SA, Harris M, Howell A: The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer 58: 163–170, 1988
Albanes D, Winick M: Are cell number and cell proliferation risk factors for cancer? JNCI 80: 772–775, 1988
Susser M, Watson W, Hopper K: Sociology in Medicine, 3rd edition. Oxford University Press, New York, 1985, pp 3–27
Doyal L: The Political Economy of Health. South End Press, Boston MA, 1979
Sander D: The Struggle for Health: Medicine and the Politics of Underdevelopment. MacMillan Publishers, London, 1985
Beardsley EH: A History of Neglect: Health Care for Blacks and Millworkers in the Twentieth-century South. University of Tennessee Press, Knoxville TN, 1987
Krieger N, Basset M: The health of black folk: disease, class and ideology in science. Monthly Review 38: 74–85, 1986
Drife JO: Breast development in puberty. Ann NY Acad Sci 464: 58–65, 1986
Knight CH, Peaker M: Development of the mammary gland. J Reprod Fert 65: 521–536, 1982
Furnival CM: Function of the normal breast: physiology and endocrine control. In: Forbes JF (ed) Breast Disease. Churchill Livingston, Edinburgh, 1986, pp 1–19
Anderson TJ, Ferguson DJP, Raab GM: Cell turnover in the ‘resting’ human breast: influence of parity, contraceptive pill, age and laterally. Br J Cancer 46: 376–382, 1982
Wellings SR, Jensen HM, Marcum RG: An atlas of sub-gross pathology of the human breast with special reference to possible precancerous lesions. JNCI 55: 231–243, 1975
Azzopardi JG: Problems in Breast Pathology. WB Saunders, London, 1977
Taylor-Papadimitriou J, Lanne EG, Chang SE: Cell lineages and interactions in neoplastic expression in the human breast. In: Rich MA, Hager JC, Furmanski P (eds) Understanding Breast Cancer. Marcel Dekker, New York, 1983, pp 215–246
Squartini F, Bistorchi M, Sarnelli R, Basolo F: Early pathologic changes in experimental and human breast cancer: facts and comments. Ann NY Acad Sci 464: 231–261, 1986
Moolgavkar SH, Day SE, Stevens RG: Two-stage model of carcinogenesis: Epidemiology of breast cancer in females. JNCI 65: 559–569, 1980
Chavkin W: Introduction. In: Chavkin W (ed) Double Exposure: Women's Health Hazards on the Job and at Home. Monthly Review Press, New York, 1984, pp 1–13
Tokunga M, Tokuaka S, Lind CE: Breast cancer in atomic bomb survivors. Gann 32: 167–177, 1986
Boice JD Jr, Manson RR: Breast cancer in women after repeated fluoroscopic examinations of the chest. JNCI 59: 823–832, 1977
Buell PL: Changing incidence of breast cancer in Japanese-American women. JNCI 51: 1479–1483, 1973
Staszweski J, Haenzel WM: Cancer mortality among the Polish-born in the United States. JNCI 35: 291–297, 1965
Newell GR, Mills PK: Cancer rates in Hispanic women related to social and economic factors. In: Stellman SD (ed) Women and Cancer. Harrington Park Press, New York, 1987, pp 23–35
Petrakis NL: Physiologic, biochemical, and cytological aspects of nipple aspirate fluid. Breast Cancer Res Treat 8: 7–19, 1986
Rizk SL, Sky-Peck HH: Comparison between concentration of trace elements in normal and neoplastic human breast tissue. Cancer Res 44: 5390–5394, 1984
Rogan WJ, Bagniewska A, Domstra T: Current concepts: pollutants in breast milk. N Engl J Med 302: 1450–1453, 1980
Rogan WJ, Gladen BC, McKinney JD, Carreras N, Hardy P, Thullen J, Tingelstad J, Tully M: Polychlorinated biphenyls (PCBs) and dichloroethane (DDE) in human milk: effects of maternal factors and previous lactation. Am J Public Health 76: 172–177, 1986
Wynder EL, Brous IJ, Hirayama T: A study of the epidemiology of breast cancer. Cancer 13: 559–601, 1960
Valaoras VG, Trichopoulos D, Polychronopoulou A: Lactation and reproductive histories of breast cancer patients in Greater Athens, 1965–67. Int J Cancer 4: 350–363, 1969
Yuasa S, MacMahon B: Lactation and reproductive histories of breast cancer patients in Tokyo, Japan. Bull Wld Hlth Org 42: 195–204, 1970
Mirra AP, Cole P, MacMahon B: Breast cancer in an area of high parity: Sao Paolo, Brazil. Cancer Res 31: 77–83, 1971
Brinton LA, Hoover R, Fraumeni JF Jr: Reproductive factors in the aetiology of breast cancer. Br J Cancer 47: 757–762, 1983
Rosenberg L, Palmer JR, Kaufman DWS, Strom BL, Schottenfeld D, Shapiro S: Breast cancer in relation to the occurrence and time of induced and spontaneous abortion. Am J Epidemiol 127: 981–989, 1988
Kaufman DW, Miller DR, Rosenberg L, Helmrich SP, Stolley P, Schottenfeld D, Shapiro S: Noncontraceptive estrogen use and the risk of breast cancer. JAMA 252: 63–67, 1984
Buring JE, Hennekens CH, Lipnick RJ, Willett W, Stampfer MR, Rosner B, Peto R, Speizer FE: A prospective cohort study of postmenopausal hormone use and risk of breast cancer in US women. Am J Epidemiol 125: 939–947, 1987
Vessey MP, McPherson K, Yeates D, Doll R: Oral contraceptive use and abortion before first term pregnancy in relation to breast cancer risk. Br J Cancer 43: 327–331, 1982
Clavel F, Benham ASE, Sitruk-Ware R, Mauvais-Jarvis P, Flamant P: Breast cancer and oral contraceptives: a review. Contraception 32: 553–569, 1985
Stadel BV, Rubin GL, Webster LA, Schlesselman JJ, Wingo PA: Oral contraceptives and breast cancer in young women. Lancet ii: 970–973, 1985
Paul C, Skegg DCG, Spears FGS, Kaldor JM: Oral contraceptives and breast cancer: a national study. Br Med J 293: 723–726, 1986
Schlesselman JJ, Stadel BV, Murray P, Lai S: Breast cancer risk in relation to type of estrogen contained in oral contraceptives. Contraception 36: 595–613, 1987
Skegg DCG: Potential for bias in case-control studies of oral contraceptives and breast cancer. Am J Epidemiol 127: 205–212, 1988
Myers JS: Cell proliferation in normal human ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine: effect of menstrual phase, age, and oral contraceptive hormones. Human Pathology 8: 67–81, 1987
Hirohata T, Nomura AMY, Hankin JH, Kolonel LN, Lee J: An epidemiological study on the association between diet and breast cancer. JNCI 78: 595–600, 1987
Malet C, Gompel A, Spritzer P, Kuttenn F, Mauvais-Jarvis P: Effect of estradiol and the synthetic progestin Promegestone (R5020) on the proliferation of human mammary cells in culture. Ann NY Acad Sci 464: 489–492, 1986
Thijssen JHH, Von Londeghem AJ, Poortman J: Uptake and concentration of steroid hormones in mammary tissues. Ann NY Acad Sci 464: 106–116, 1986
Nagasawa H, Yanni R, Taniguchi M: Importance of mammary gland DNA synthesis in carcinogen-induced mammary tumorigenesis in rats. Cancer Res 36: 2225–2226, 1976
Russo J, Saby J, Isenberg WM, Russo IH: Pathogenesis of mammary carcinomas induced in rats by 7,12-dimethylben[a]anthracene. JNCI 59: 435–445, 1977
Russo IH, Russo J: Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz[a]anthracene. JNCI 61: 1439–1449, 1978
Russo J, Russo IH: DNA labeling index and structure of the rat mammary gland as determinant of its susceptibility to carcinogenesis. JNCI 61: 1451–1459, 1978
Russo J, Wilgood G, Russo IH: Susceptibility of the mammary gland to carcinogenesis. I. Differentiation of the mammary gland as determinant of tumor incidence and type of lesion. Am J Pathology 96: 721–733, 1979
Russo J, Russo IH: Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence. Am J Pathology 100: 497–508, 1980
Russo J, Russo IH: Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis. Cancer Res 40: 2677–2687, 1980
Dao TL, Back FG, Greiner JM: Mammary carcinogenesis by 3-methylcholanthracene. II. Inhibitory effect of pregnancy and lactation on tumor induction. JNCI 25: 991–1002, 1960
Davies JE, Edmundson WF, Raffonelli A, Cassady JC, Morgade C: The role of social class in human pesticide pollution. Am J Epidemiol 96: 334–341, 1972
Finklea J, Priester LE, Creason JP, Hauser T, Hinners T, Hammers DI: Polychlorinated biphenyl residues in human plasma expose a major urban pollution problem. Am J Public Health 62: 645–651, 1972
American Cancer Society: Cancer in the economically disadvantaged. American Cancer Society, New York, 1986
Pollack S, Grozuczak J: Reagan, toxics and minorities. Urban Environment Conference, Washington DC, 1984
Robinson JC: Racial inequality and the probability of occupation-related injury or illness. Milbank Memorial Fund Quarterly 62: 567–590, 1984
Lee C: Toxic wastes and race in the United States: a national report on the racial and social economic characteristics of communities with hazardous waste sites. United Church of Christ, New York, 1987
U.S. Dept. of Health and Human Services: Report of the Secretary's task force on black and minority health, vol. 1: Executive summary. [1985 0-487-673 (WL3)]. U.S. Government Printing Office, Washington DC, 1985
U.S. Dept. of Health and Human Services: Health status of minorities and low income groups. DHHS Pub. No. (HRSA) HRS-P-DV 85-1. U.S. Government Printing Office, Washington DC, 1985
Farley R: The quality of life for Black Americans twenty years after the civil rights revolution. Milbank Memorial Fund Quarterly 65 (Suppl 1): 9–34, 1987
Henshaw SK: Induced abortions: a worldwide perspective. Fam Plan Perspectives 18: 250–254, 1986
Potts M, Diggory P, Peel J: Abortion. Cambridge University Press, Cambridge, 1977
Epstein SS, Swartz JB: Fallacies of lifestyle cancer theories. Nature 289: 127–130, 1981
Beer AE, Billingham RE: Adipose tissue: a neglected factor in the aetiology of breast cancer? Lancet ii: 296, 1978
Robinson WS: Ecological correlations and the behavior of individuals. Am Sociol Rev 15: 351–357, 1950
Alker HR Jr: A typology of ecologic fallacies. In: Doggan M, Rokkan S (eds) Social Ecology. MIT Press, Cambridge MA, 1969, pp 69–86
Stavraky KM: The role of ecologic analysis in studies of the etiology of disease: a discussion with reference to large bowel cancer. J Chron Dis 29: 435–444, 1976
Morgenstern H: Uses of ecologic analysis in epidemiologic research. Am J Public Health 72:1336–1344, 1982
Selvin S: Two issues concerning the analysis of grouped data. Eur J Epidemiol 3: 284–287, 1987
Piantadosi S, Byar DP, Green SB: The ecological fallacy. Am J Epidemiol 127: 893–904, 1988
Davis GA, Donaldson OF: Blacks in the United States: a geographic perspective. Houghton Mifflin, Boston MA, 1975
Jones J: Labor of Love, Labor of Sorrow: Black Women, Work and the Family from Slavery to the Present. Basic Books, New York, 1985
Rassin DK, Richardson CJ, Daranowski T, Nader TR, Guenther N, Bee DE, Brown JP: Incidence of breast feeding in a low socioeconomic group of mothers in the United States: ethnic patterns. Pediatrics 73: 132–137, 1984
Young S, Kaufman M: Promoting breastfeeding in a migrant health center. Am J Public Health 78: 523–525, 1988
Gebhard PH, Pomeroy WB, Martin CE, Christenson CV: Pregnancy birth and abortion. Harper & Bros., New York, 1958
Calderone MS: Abortion in the United States. Hoeber-Harper Books, New York, 1958
Henshaw SK, O'Reilly K: Characteristics of abortion patients in the United States, 1979 and 1980. Fam Plan Perspectives 15: 5–16, 1983
Henshaw SK, Binkin NH, Blaine E, Smith JC: A portrait of American women who obtain abortions. Fam Plan Perspectives 17: 90–96, 1985
Centers for Disease Control: Hysterectomy among women of reproductive age, United States, update for 1981–1982. In: CDC Surveillance Summaries 33 (No. 3SS), 1984, pp 1SS-6SS
Rose G: Sick individuals and sick populations. Int J Epidemiol 14: 32–38, 1985
National Center for Health Statistics: Plan and operation of the Second National Health and Nutrition Examination Survey, 1976–1980. Vital and Health Statistics, Series 1, No. 15, DHHS Pub No. (PHS) 81-1317. U.S. Government Printing Office, Washington DC, 1981
Kannel WB, Castelli WP, McNamara P: Cigarette smoking and risk of coronary heart disease: epidemiologic clues to pathogenesis — The Framingham Study. National Cancer Institute Monograph No. 28. National Cancer Institute, Bethesda MD, 1968
Cairns J: The treatment of diseases and the war against cancer. Sci Am 253: 51–59, 1985
Bailar JC III, Smith EM: Progress against cancer? N Engl J Med 314: 1226–1232, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Krieger, N. Exposure, susceptibility, and breast cancer risk: A hypothesis regarding exogenous carcinogens, breast tissue development, and social gradients, including black/white differences, in breast cancer incidence. Breast Cancer Res Tr 13, 205–223 (1989). https://doi.org/10.1007/BF02106571
Issue Date:
DOI: https://doi.org/10.1007/BF02106571